Business Context and Reporting Period
This Form 6-K filing by Nano Dimension Ltd. covers the month of August 2017. The report serves to furnish a corporate presentation dated August 8, 2017, to the U.S. Securities and Exchange Commission as Exhibit 99.1.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a cover for a corporate presentation rather than a financial statement containing numerical data.
Material Changes
No material changes in financial performance or operations are detailed in this specific filing text. The document references the Company's annual report for the year ended December 31, 2016, for historical context and risk details.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing contains forward-looking statements regarding market potential, anticipated sales timelines, and opportunities in bio-printing of stem cells.
- Uncertainty: Management notes that these projections are based on current expectations and are inherently uncertain. Actual results may differ materially.
- Risk Reference: Detailed risks and uncertainties are referenced in the Company's annual report for the year ended December 31, 2016.
- Update Policy: The Company assumes no obligation to update forward-looking statements except as required by applicable securities laws.
Key Facts for Investor Verification
- Verify the content of the corporate presentation (Exhibit 99.1) for specific financial projections and strategic updates not included in this cover letter.
- Review the annual report for the year ended December 31, 2016, for detailed risk factors and historical financial data.
- Note that the filing explicitly disclaims any obligation to update forward-looking statements regarding bio-printing and sales timelines.